Top 5 Diversified Bank Companies To Buy Right Now

Medical device maker St. Jude got a lift Friday for two reasons: Fitch Ratings maintained the company’s debt ratings and the FDA set an October 9 date for a review that could result in approval of a new heart device.

Shares of St. Jude Medical (STJ), best known for its�implantable heart defibrillators,�were up $1.70, or more than 3.%, to $52.66.

Fitch reiterated its bond ratings and said that President Barack Obama�� health-care overhaul should modestly improve volume growth for St. Jude’s products as more people get health insurance�over the next two years, according to MarketWatch in�this report.

The reiteration on debt and the safety of leverage levels is important with discussion of the device, the CardioMEMs’ Champion Heart Failure Monitoring�System, back on the calendar. St. Jude�has a 19% stake in�CardioMEMs and the option for an outright purchase.�While the FDA date announcement was news, this is a review “yet again” of the monitoring�system for FDA approval, write�Leerink Swann Research Analysts Danielle Antalffy and Robert Marcus

Hot Gold Companies To Buy For 2015: Obagi Medical Products Inc.(OMPI)

Obagi Medical Products, Inc., a specialty pharmaceutical company, develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems. It offers Obagi Nu-Derm System, including prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System comprises Vitamin C with 4% hydroquinone system to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Professional-C products consisting of Vitamin C serums for the treatment of antioxidant protection, fine lines, wrinkles, and hyperpigmentation. The company also provides ELASTIderm Eye and D�olletage, which increases the elasticity and skin tone of eyes, face, neckline, and chest; ELASTILash Eyelash Solution that enhances the appearance of thickness and fullness of eyelashes; CLENZIderm M.D. Systems and Tretinoin for treating acne; and Obagi Rosaclear System used for the treatment of rosacea. In addition, it offers Refissa and Blue Peel RADIANCE used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole used for the treatment of rosacea; Obagi Blue Peel Essential Kit used for the treatment of fine lines, wrinkles, and hyperpigmentation. Further, the company licenses non-prescription product concepts under the Obagi trademark to a Japanese-based pharmaceutical company for sale through consumer distribution channels in Japan. Obagi Medical Products, Inc. sells its products through sales force and distribution partners in the United States, North and Central America, Europe, the Middle East, and Asia to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Lon g Beach, California.

Advisors' Opinion:

• [By David Williamson]

  Though many excited traders had hoped to see the bidding war continue between Valeant Pharmaceuticals (NYSE: VRX  ) and Merz over Obagi Medical Products (NASDAQ: OMPI  ) and a subsequent run-up in the stock price of the smaller dermatological products maker, Merz has now walked away from the table, leaving the highly acquisitive Valeant the victor. In this video, Motley Fool health care analyst David Williamson gives us some background on these companies and tells us how Valeant plans to profit from the deal, and describes for investors why this is a win both for Obagi and for Valeant.

• [By Keith Speights]

  "Bidness" is good
  Last week, Obagi Medical Products (NASDAQ: OMPI  ) made our list of humongous performers after Valeant Pharmaceuticals� (NYSE: VRX  ) announced a $344 million bid for the company. This week saw a bidding frenzy, with Obagi shares jumping another 29%.

Top 5 Diversified Bank Companies To Buy Right Now: Rentech Inc (RTK)

Rentech, Inc. (Rentech), incorporated in 1981, is a provider of clean energy solutions. The Company owns and operates a nitrogen fertilizer plant in East Dubuque, Illinois, that manufactures and sells natural gas-based nitrogen fertilizer products within the corn-belt region in the United States. It is developing energy projects to produce certified synthetic fuels and electric power from carbon-containing materials, such as biomass, waste and fossil resources. Its technologies can produce synthesis gas (syngas) from biomass and waste materials, and convert syngas from its own or other gasification technologies into complex hydrocarbons (the Rentech Process) that are then upgraded into fuels using refining technology that it licenses. In addition to developing projects using these technologies, it is pursuing the licensing of its technologies to developers of projects that are expected to produce fuels and/or power. In May 2011, it acquired majority interest in ClearFuels Technology Inc. In May 2013, Rentech Inc acquired the entire share capital of Fulghum Fibres Inc. In August 2013, Rentech Inc announced that a subsidiary of the Company closed the sale of approximately 450 acres in Natchez, Mississippi to Adams County, Mississippi.

The Rentech Process is a technology based on Fischer-Tropsch (FT) chemistry, which converts syngas that can be produced from a range of biomass, waste and fossil resources into hydrocarbons. These hydrocarbons can be processed and upgraded into synthetic fuels, such as military and commercial jet fuels and low sulfur diesel fuel, as well as waxes and chemicals. Unlike some other alternative transportation fuels, such as ethanol, fuels produced from the Rentech Process can be transported and used in existing infrastructure, including pipelines and engines without blending restrictions. Its technology portfolio also includes the Rentech-SilvaGas biomass gasification technology (the Rentech-SilvaGas Technology), which enables it to offer integrated technologies t! hat can convert biomass and wastes to syngas and into clean fuels and electric power.

The Rentech Process can produce synthetic diesel fuels (RenDiesel1 fuels), which are clean burning having lower emissions of regulated pollutants, such as nitrogen oxides, sulfur oxides and particulate matter, than traditional petroleum-based diesel fuels. The Rentech Process also can produce synthetic jet fuel (RenJet fuel), which when blended with conventional jet fuel meet jet fuel specifications for military jet fuel and commercial Jet A and Jet A-1 fuels. It is developing a proposed project near Natchez, Mississippi (the Natchez Project) designed to produce approximately 30,000 barrels per day of synthetic fuels and chemicals and approximately 120 megawatts of power. It is evaluating alternative configurations for the Natchez site, which would initially be smaller in scale. The alternate configurations may use various feed-stocks alone or in various combinations, and include proportions of waxes and chemicals as products.

The Company owns, through its wholly owned subsidiary, Rentech Energy Midwest Corporation (REMC), a nitrogen fertilizer manufacturing plant that uses natural gas as its feedstock to produce syngas and then nitrogen fertilizer products. The products, the Company can produce include renewable synthetic diesel and jet fuels, naphtha and power from biomass resources; synthetic diesel and jet fuels, naphtha and power from fossil or fossil and biomass resources, and paraffinic waxes, solvents and specialty chemicals.

The Company competes with ExxonMobil, the Royal Dutch/Shell group, Statoil, BP and Sasol.

Advisors' Opinion:

• [By Rich Duprey]

  Alternative energy specialist�Rentech� (NASDAQ: RTK  ) �will be�buying back�up to $25 million worth of company stock through the rest of the year, the board of directors announced Monday.

Top 5 Diversified Bank Companies To Buy Right Now: Travelzoo Inc(TZOO)

Travelzoo Inc., an Internet media company, together with its subsidiaries, publishes travel and entertainment deals from travel and entertainment companies, and local businesses in North America and Europe. Its publications and products include the Travelzoo Websites, such as travelzoo.com, travelzoo.ca, travelzoo.co.uk, travelzoo.de, www.travelzoo.es, and travelzoo.fr; the Travelzoo Top 20 e-mail newsletter; and the Newsflash e-mail alert service. The company also operates SuperSearch, a pay-per-click travel search tool; Travelzoo Network, a network of third-party Websites that list deals published by Travelzoo; and Fly.com, a travel search engine that allows users to find the best prices on flights from various airlines and online travel agencies. In addition, it provides Local Deals and Getaways services that allow its subscribers to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants through the Travelzoo Website. As of December 31, 2011, the company?s advertiser base included approximately 2,000 travel companies, entertainment companies, and local businesses, including airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Peter Graham]

  The Q1 2014 Tripadvisor Inc (NASDAQ: TRIP) earnings report is due after the market closes on Tuesday, May 6th, with investors and traders alike who follow either the stock or large cap Priceline Group Inc (NASDAQ: PCLN), mid cap Expedia Inc (NASDAQ: EXPE) and small caps Travelzoo Inc (NASDAQ: TZOO) and Orbitz Worldwide, Inc (NYSE: OWW) should be paying attention to it. Aside from the Tripadvisor Inc earnings report, it should be said that Travelzoo Inc released 1Q 2014 earnings on April 17th and Expedia Inc released earnings last Thursday while the Q1 2014 Orbitz Worldwide earnings report is due today before the market opens and the Priceline Group Inc earnings report is due out on Thursday, May 8, at 9:30AM EDT. However, Tripadvisor Inc is a little different from these other travel booking companies as its main focus is to provide travel advice or reviews written by real travelers (which obviously leads to travel bookings that they make money on).

• [By Rich Smith]

  If you are a Travelzoo (NASDAQ: TZOO  ) shareholder but own fewer than 25 shares, management would really appreciate it if you would just go away.

Top 5 Diversified Bank Companies To Buy Right Now: Image Systems Nordic AB (IS)

Image Systems Nordic AB, formerly Digital Vision AB, is a Sweden-based company active in the media industry. The Company specializes in high resolution image processing, film scanning and solutions for motion analysis. The Company operates within three business areas: Media, Defense and Motion. The Company�� product portfolio includes the Nucoda software products, providing a suite of colour grading and finishing solutions used in film and television post production; the Phoenix software products, providing image restoration tools for film archives and content owners; the Golden Eye film scanners, which provide high resolution scanning, archive and restoration, and the Image Systems Motion Unit with its TEMA software platform, providing a range of motion analysis solutions, among others. As of March, 1, 2012, the Company acquired Sawco Holding AB and RemaControl Sweden AB. As of March 31, 2012, the Company�� largest shareholder was Tibia Konsult AB (19.1%). Advisors' Opinion:

• [By Geoff Gannon]

  ��The ranking exercise (is) based on growth and fundamental analysis. EXC ranks at the bottom in both analyses��op 4 results are Apple, BHP Billiton (BHP), Mosaic (MOS) and Rio Tinto (RIO). MOS was eliminated as it has one year of negative FCF.